Mutational analysis of the β-catenin gene in gastric carcinomas

Tumor Biology

Volumn 22, Issue 2, 2001, Pages 123-130

  Sasaki, Yasushi ^a   Morimoto, Ichiro ^a   Kusano, Masanobu ^a,b   Hosokawa, Masao ^b   Itoh, Fumio ^a   Yanagihara, Kazuyoshi ^c   Imai, Kohzoh ^a   Tokino, Takashi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIYUKAI SAPPORO HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Gastric carcinoma, human; Immunohistochemistry; Somatic mutation; Catenin

Indexed keywords

BETA CATENIN;

ADENOMATOUS POLYP; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL ADHESION; COLORECTAL CANCER; ENDOMETRIUM CANCER; EXON; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SOMATIC MUTATION; STOMACH CARCINOMA;

EID: 0035179209     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050606     Document Type: Article

References (43)

1. Signal transduction of β-catenin
2. β-Catenin: A key mediator of Wnt signaling
3. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
4. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
5. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma
6. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
7. Stabilization of β-catenin by genetic defects in melanoma cell lines
8. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
9. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
10. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
11. β-Catenin mutation in carcinoma of the uterine endometrium
12. Mutations of the β-catenin gene in endometrial carcinomas
13. Sporadic medulloblastomas contain oncogenic β-catenin mutations
14. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
15. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
16. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
17. β-Catenin mutations in cell lines established from human colorectal cancers
18. Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma
19. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
20. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer
21. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma
22. Characterization of the APC gene in sporadic gastric adenocarcinomas
23. β-Catenin expression in human cancers
24. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
25. Expression of cadherin-catenin cell adhesion molecules, phosphorylated tyrosine residues and growth factor receptor-tyrosine kinases in gastric cancers
26. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
27. The expression of β-catenin in non-small-cell lung cancer: A clinicopathological study
28. Downregulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis
29. Reduction in membranous expression of β-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer
30. Cadherin-catenin expression in primary colorectal cancer: A survival analysis
31. Expression of β-catenin, β-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas
32. Expression of E-cadherin and β-catenin in patients with colorectal carcinoma
33. E-cadherin and α-, β- and γ-catenin protein expression in relation to metastasis in human breast carcinoma
34. No evidence for mutations in the α- and β-catenin genes in human gastric and breast carcinomas
35. β- and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer
36. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer
37. Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma
38. Transformation by Wnt family proteins correlates with regulation of β-catenin
39. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer
40. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas
41. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
42. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of $-catenin
43. A truncated β-catenin disrupts the interaction between E-cadherin and β-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines